← back to search

Peter Winskill

Imperial College London · GB
Area of research
Public Health, Environmental and Occupational Health · Modeling and Simulation
Research interest
Research interests include COVID-19 epidemiological studies, Malaria Research and Control, Mosquito-borne diseases and control, and SARS-CoV-2 and COVID-19 Research.
h-index
40
citations
19,490
works
136
NIH funding
primary concept
Medicine
email

Recent publications

The benefits of investments to combat HIV, tuberculosis, and malaria for primary healthcare from 2000 to 2023: An economic modeling analysis.
2026cited by 1position: contributordoi
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic
Nature Communications 2025cited by 5position: middledoi
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic.
2025cited by 3position: contributordoi
The benefits of investments to combat HIV, tuberculosis and malaria for primary health care, 2000–2023: an economic modeling analysis
2025cited by 1position: contributordoi
The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study.
2025cited by 1position: contributordoi
Public health impact of catch-up vaccination or additional booster doses with pre-erythrocytic malaria vaccine R21/Matrix-M: a modelling study
2025cited by 0position: contributordoi
The potential of gene drives in malaria vector species to control malaria in African environments.
2024cited by 25position: contributordoi
The potential of gene drive releases in malaria vector species to reduce the malaria burden in different African environments
2024cited by 4position: contributordoi
Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach
Nature Communications 2023cited by 34position: middledoi
Seasonal dynamics of <i>Anopheles stephensi</i> and its implications for mosquito detection and emergent malaria control in the Horn of Africa.
2023cited by 28position: contributordoi
Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach.
2023cited by 25position: contributordoi
Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study
PLoS Medicine 2023cited by 20position: middledoi
Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis
Vaccine 2023cited by 18position: contributordoi
Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.
2023cited by 16position: contributordoi
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa
Nature Communications 2023cited by 13position: middledoi
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa.
2023cited by 11position: contributordoi
Estimating the burden of severe malarial anaemia and access to hospital care in East Africa
Nature Communications 2023cited by 9position: firstdoi
The societal cost of vaccine refusal: A modelling study using measles vaccination as a case study
Vaccine 2023cited by 7position: contributordoi
Estimating the burden of severe malarial anaemia and access to hospital care in East Africa.
2023cited by 3position: contributordoi
Optimising the deployment of vector control tools against malaria: a data-informed modelling study
LSTM Online Archive (Liverpool School of Tropical Medicine) 2022cited by 65position: middle
Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic.
2022cited by 41position: contributordoi
Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study
The Lancet Global Health 2022cited by 32position: middledoi
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling.
2022cited by 29position: contributordoi
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
Vaccine 2021cited by 114position: middledoi
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
Vaccine 2021cited by 103position: contributordoi
Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria
Nature Communications 2021cited by 77position: middledoi
Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis
The Lancet Global Health 2021cited by 72position: middledoi
Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria.
2021cited by 37position: contributordoi
Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review
Wellcome Open Research 2021cited by 27position: middledoi
Health inequities and clustering of fever, acute respiratory infection, diarrhoea and wasting in children under five in low- and middle-income countries: a Demographic and Health Surveys analysis.
2021cited by 17position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2019–2026)Azra C. Ghani · National University of Singapore17 papers (2020–2025) · 11 papers (2020–2025)Patrick Walker · Imperial College London9 papers (2019–2023)Oliver J. Watson · London School of Hygiene & Tropical Medicine7 papers (2021–2025)Charles Whittaker · University of California, Berkeley7 papers (2021–2025)Alexandra B. Hogan · New South Wales Department of Health6 papers (2021–2025)Neil M. Ferguson · Public Health England5 papers (2021–2023) · 5 papers (2021–2025) · 5 papers (2020–2023)Daniel J. Laydon · Imperial College London5 papers (2021–2025)Oliver J. Watson · Imperial College London5 papers (2021–2025)Matthew Cairns · University of Hertfordshire4 papers (2021–2023)Lucy Okell · National Centre for Infectious Diseases4 papers (2022–2025) · 4 papers (2022–2025)Neil M. Ferguson · Imperial College London4 papers (2021–2023)Robert Verity · Imperial College London3 papers (2021–2022)John Stover · Policy Analysis (United States)3 papers (2025–2026) · 3 papers (2023–2025)S. Bhatt · Illumina (United States)3 papers (2021–2023)